Lo and colleagues have shown that local production of IL-23 inhibits metastatic colorectal tumour growth in vivo and that this anti-tumour activity requires CD8+ T-cells, but not CD4+ T-cells or NK cells [13]. Here, CD8A is linked to neoplasm.